SG11202009788TA - Bioxomes particles, redoxomes, method and composition - Google Patents

Bioxomes particles, redoxomes, method and composition

Info

Publication number
SG11202009788TA
SG11202009788TA SG11202009788TA SG11202009788TA SG11202009788TA SG 11202009788T A SG11202009788T A SG 11202009788TA SG 11202009788T A SG11202009788T A SG 11202009788TA SG 11202009788T A SG11202009788T A SG 11202009788TA SG 11202009788T A SG11202009788T A SG 11202009788TA
Authority
SG
Singapore
Prior art keywords
redoxomes
bioxomes
particles
composition
bioxomes particles
Prior art date
Application number
SG11202009788TA
Inventor
Sabina Glozman
Original Assignee
Orgenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orgenesis Inc filed Critical Orgenesis Inc
Publication of SG11202009788TA publication Critical patent/SG11202009788TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • B01D11/0203—Solvent extraction of solids with a supercritical fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11202009788TA 2018-04-09 2019-04-04 Bioxomes particles, redoxomes, method and composition SG11202009788TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862654771P 2018-04-09 2018-04-09
US201962794859P 2019-01-21 2019-01-21
PCT/IL2019/050391 WO2019198068A1 (en) 2018-04-09 2019-04-04 Bioxomes particles, redoxomes, method and composition

Publications (1)

Publication Number Publication Date
SG11202009788TA true SG11202009788TA (en) 2020-10-29

Family

ID=68163380

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009788TA SG11202009788TA (en) 2018-04-09 2019-04-04 Bioxomes particles, redoxomes, method and composition

Country Status (11)

Country Link
US (1) US20210052506A1 (en)
EP (1) EP3773520A4 (en)
JP (1) JP2021521141A (en)
KR (1) KR20200141080A (en)
CN (1) CN112739332A (en)
AU (1) AU2019251449A1 (en)
BR (1) BR112020020831A2 (en)
CA (1) CA3096448A1 (en)
IL (1) IL277728A (en)
SG (1) SG11202009788TA (en)
WO (1) WO2019198068A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4096687A4 (en) * 2020-01-28 2024-02-28 Orgenesis Inc Process and system for acellular therapy
US20230147602A1 (en) * 2020-03-20 2023-05-11 Orgenesis Inc. Ribonucleases for treating viral infections
WO2022204350A1 (en) * 2021-03-24 2022-09-29 Orgenesis Inc. Compositions comprising topiramate for treating dermatological conditions
US20230012448A1 (en) * 2021-06-30 2023-01-12 Getwing Biotechnology Medical Co., Ltd Methods for alleviating kidney disease and fibrosis of organ

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428008A (en) * 1989-04-14 1995-06-27 Prp, Inc. Therapeutic composition of micellar structures capable of promoting hemotasis
RU2062468C1 (en) * 1992-05-21 1996-06-20 Онкологический научный центр РАМН Method for extracting and separating cellular lipides
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
CA2272971C (en) * 1998-10-29 2008-01-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
HUE024999T2 (en) * 2004-08-26 2016-02-29 Engeneic Molecular Delivery Pty Ltd Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
US8389485B2 (en) * 2007-10-29 2013-03-05 University Of Massachusetts Encapsulated nanoparticles for nucleic acid delivery
CN102625696B (en) * 2009-06-10 2015-06-03 阿尔尼拉姆医药品有限公司 Improved lipid formulation
EA032941B1 (en) * 2010-03-12 2019-08-30 БЕРГ ЭлЭлСи INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND USE THEREOF
US9119974B2 (en) * 2011-03-04 2015-09-01 Ahmed H. Al-Qahtani Skin cream
WO2013052167A2 (en) * 2011-06-02 2013-04-11 The Regents Of The University Of California Membrane encapsulated nanoparticles and method of use
EP3372280B1 (en) * 2011-07-07 2020-09-16 Howard Foundation Holdings Limited Improvements in or relating to visual performance
US11559580B1 (en) * 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
CN106061510B (en) * 2013-12-12 2020-02-14 布罗德研究所有限公司 Delivery, use and therapeutic applications of CRISPR-CAS systems and compositions for genome editing
WO2016205749A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
US11116771B2 (en) * 2016-01-29 2021-09-14 Oncoceutics, Inc. G protein-coupled receptor (GPCR) modulation by imipridones
IT201700043316A1 (en) * 2017-04-20 2018-10-20 Lipogems Int S P A DRUG DELIVERY SYSTEM
WO2019022671A1 (en) * 2017-07-28 2019-01-31 National University Of Singapore Biomolecular composites comprising modified cell ghosts
KR102015116B1 (en) * 2018-05-04 2019-10-21 (주)메디톡스 Extracellular vesicle isolated from recombinant microorganism comprising polynucleotide encoding target protein and use thereof
US20230147602A1 (en) * 2020-03-20 2023-05-11 Orgenesis Inc. Ribonucleases for treating viral infections

Also Published As

Publication number Publication date
CN112739332A (en) 2021-04-30
EP3773520A4 (en) 2021-12-22
CA3096448A1 (en) 2019-10-17
AU2019251449A1 (en) 2020-11-12
IL277728A (en) 2020-11-30
KR20200141080A (en) 2020-12-17
US20210052506A1 (en) 2021-02-25
EP3773520A1 (en) 2021-02-17
JP2021521141A (en) 2021-08-26
BR112020020831A2 (en) 2021-04-13
WO2019198068A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
PL3283435T3 (en) Composition, particulate materials and methods for making particulate materials.
SG11202003790PA (en) Composition and method
GB201905559D0 (en) Composition and method
IL277728A (en) Bioxomes particles, redoxomes, method and composition
GB201909542D0 (en) Composition and method
GB2576614B (en) Compositions, uses and methods
GB201804163D0 (en) Uses, compositions and methods
GB201904104D0 (en) Composition, method and use
GB2564511B (en) Composition, method and use
GB201805016D0 (en) Composition, method and use
GB201705124D0 (en) Composition, method and use
PL3448555T3 (en) Solid decontamination composition, method for obtaining same, and uses thereof
GB2579687B (en) Composition and method
GB201914777D0 (en) Composition and method
ZA201904187B (en) Method and composition
ZA201904328B (en) Composition, application thereof and treatment method
GB201818328D0 (en) Method and composition
GB201817000D0 (en) Method and composition
GB201900569D0 (en) Composition, method and use thereof
GB201800877D0 (en) Method and composition
HK1257196A1 (en) Composition, method for preparing same and use thereof
GB201714238D0 (en) Composition and method
AU2017904424A0 (en) Composition and method
AU2018902779A0 (en) Composition and method
AU2018902656A0 (en) Composition and method